Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

Mystery of relapse in acute myeloid leukaemia uncovered

Mystery of relapse in acute myeloid leukaemia uncovered

AML: Two distinct patterns of stem cells explain relapse

AML: Two distinct patterns of stem cells explain relapse

Physicists make quantum leap in understanding life's nanoscale machinery

Physicists make quantum leap in understanding life's nanoscale machinery

Combination approach improves power of new cancer therapy

Combination approach improves power of new cancer therapy

Amber warning for the UK’s access to new medicines post Brexit

Amber warning for the UK’s access to new medicines post Brexit

Using 'sticky' nanoparticles, researchers develop strategy to boost body's cancer defenses

Using 'sticky' nanoparticles, researchers develop strategy to boost body's cancer defenses

FDA approves rituximab plus hyaluronidase combination for treatment of follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukaemia

FDA approves rituximab plus hyaluronidase combination for treatment of follicular lymphoma, diffuse large B-cell...

$Axicabtagene ciloleucel for refractory aggressive non-Hodgkin lymphoma$

Axicabtagene ciloleucel for refractory aggressive non-Hodgkin lymphoma

Bleeding or clotting in elderly patients with cancer-associated venous thromboembolism: which is worse?

Bleeding or clotting in elderly patients with cancer-associated venous thromboembolism: which is worse?

Early metabolic response determination by FDG-PET allows substantial reduction of chemo and toxicity for advanced stage Hodgkin lymphoma

Early metabolic response determination by FDG-PET allows substantial reduction of chemo and toxicity for advanced...

More from ecancer